INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

Recruiting now · Not applicable

Conditions studied: Acute Leukemia, Multiple Myeloma, Squamous Cell Carcinoma, Pleural Mesothelioma, Pancreatic Cancer, Bladder Cancer, Ovarian Cancer, Melanoma, Pediatric Acute Lymphoblastic Leukemia, Chronic Leukemia, Myeloproliferative Disorders, Myelodysplastic Disorders

In brief

This is a multicenter, experimental preclinical study conducted on primary samples from patients diagnosed with hematological or solid neoplasms defined as high risk. The study will be prospective, based on the consecutive enrollment of eligible patients at each participating institution.

Key facts

Study ID
NCT07403630
Run by
Azienda Ospedaliero-Universitaria di Parma
People needed
300
Starts
2023-05-31
Expected to finish
2028-02-12
Last updated by the study team
2026-02-17

Who can join

Age: 1 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.